Contribute to higher efficiency and quality in examination, monitoring and treatment of patients

A New Sensor for Respiratory Monitoring

Breathing is one of the body’s most fundamental physiological functions. Eupnea provides a wireless sensor for monitoring breathing frequency and patterns. The included software notifies if changes in breathing.

In order to take advantage of the important clinical relevance of respiratory rate, the measurements must be performed correctly and accurately. Today’s standard for measuring breathing frequency is manuel counting. This is time consuming, resource intensive, inaccurate and periodic in execution. Eupnea’s sensor solves all these challenges, while simultaneously improving the performance of all tasks.

The sensor is suitable for use in the primary health service for triage optimizing at emergency rooms; the secondary health system at hospitals; as well as in home monitoring and treatment for large patient groups at risk (Covid/COPD).

Best Features of Our Product

Respiratory monitoring is a crucial aspect of patient care in hospitals, however it is frequently omitted, inaccurately measured and not recorded, leading to poor monitoring that is involved in 31% of hospital preventable deaths.

The sensor from Eupnea is pasted on the chest. Using an accelerometer, gyroscope and AI algorithms, collected in a wireless sensor technology, Eupnea can more accurately and reliably measure respiratory rate, distinguish between different breathing patterns and alert to changes that give clinicians and patients valuable information on disease development.

RELIABLE

Accurate monitoring and notification. Provides dependable data for safe observation of patients.

CONTINUOUS

Long lasting ongoing monitoring with notification of changes. Potential use over long periods, also across treatment courses. Resistant to water and movement.

USER-FRIENDLY

Easy to use for patients and health care personell. Effortless attachment and handling in treatment course and at home.

AFFORDABLE

A single sensor is available at at reasonable price. Provides cost savings along with reliable vital measurements.

LAUNCH

The vision is that the sensor will be approved for clinical use in the spring of 2024, and that hospitals or emergency rooms can use the tool for continuous measurement of breathing frequency during 2024 and 2025. If you are interested in newsletters about launch, send us a message.

Sepsis

Sepsis is one of the leading causes of mortality in intensive care units. The diagnosis is made based on known infection and systemic inflammatory response (SIRS), where three of the vital the signs are

  • Temperature
  • Heart rate
  • Respiratory rate

The measurement of the vital signs is nevertheless underestimated. Respiratory rate is significantly correlated with the severity of sepsis, how early registration of the breath will contribute to early identification of the most seriously ill, thus improving the prognosis

Pneumonia

Pneumonia is usually caused by infection with viruses or bacteria, and less commonly by other microorganisms. Identifying the responsible pathogen can be difficult.

Diagnosis is often based on symptoms and physical examination. Symptoms can include:

  • Difficulty breathing
  • Productive or dry cough
  • Chest pain
  • Fever

Pneumonia is an infection with a possible serious outcome, especially among the elderly. Outbreaks of pneumonia, such as the COVID-19 pandemic, pose major medical, social and economic challenges worldwide.

Respiratory rate is among the variables included in diagnostic criteria for severe pneumonia and clinically stable condition, as well as being an important marker for predicting mortality due to the disorder. Measurement of respiratory rate could be of great value for diagnosis, prognosis and treatment of disease in this context.

Eupnea sensor will enable low-threshold monitoring of patients in their own home care homes and nursing homes. anticipate disease progression early that enables measures to prevent hospitalization.

Cardiac arrest

Occurs when the rhythm of the heart stops. A number of factors can cause sudden cardiac arrest. Two of the most common are ventricular and atrial fibrillation.

Early symptoms of cardiac arrest are often warning signs. If you are in cardiac arrest, you may:

  • Become dizzy
  • Shortness of breath
  • Feel fatigued or weak
  • Vomit
  • Experience heart palpitations

Respiratory rate is better at predicting cardiac arrest than both heart rate and blood pressure, with an increase in respiratory rate observed several hours before cardiac arrest. This indicates that the measurement of respiratory rate may contribute to early diagnosis and treatment of serious cordial events.

COPD exacerbation

A person with chronic obstructive pulmonary disease (COPD) experiences long-term, progressive damage to their lungs This affects airflow to the lungs. With COPD, frequent exacerbations are common, often triggered by viral infections. The deterioration contributes to permanently reduced lung function and increased disease progression. This is another main cause of morbidity and mortality in COPD.

Many COPD patients experience reduced activity levels and increased social isolation with increasing disease progression. This can contribute to anxiety and depression, and overall a reduced quality of life.

Examples of COPD exacerbation symptoms include:

  • Fast and shallow breathing pattern
  • Couching
  • Shortness of breath
  • Excessively sleepiness or confusion
  • Lower oxygen levels than normal
  • Wheezing more than usual

With Eupnea sensor, respiratory frequency can be monitored daily at home in patients with COPD. In these patients, breathing rate increases significantly days before they require hospitalization because of COPD. Eupnea’s sensor will be able to detect changes in breathing frequency and breathing pattern at an early stage point. We hope to be able to anticipate the disease mechanisms and prevent exacerbations and offer a window of opportunity for early intervention.

Diagnostic

Among vital parameters, respiratory rate is more closely associated with the severity of sepsis, cardiac arrest and death than both heart rate and blood pressure. The COVID-19 pandemic has corrected attention to the importance of effective measurement of respiratory rate.

Research shows that increased respiratory rate is better at predicting cardiac arrest than both heart rate and blood pressure, with an increase in
respiratory rate observed several hours before cardiac arrest . This indicates that the measurement of respiratory rate may contribute to early diagnosis and treatment of serious cordial events.

Eupnea’s sensor technology thus provides insight into a very useful parameter too early diagnosis of these serious conditions. The result is to be able to reduce the need for intensive care, length of hospital stay and mortality.

Partners